Refractory anti-synthetase syndrome treated with rituximab.
Ball
Elisabeth M A
EM
Savage
Eimear M
EM
Pendleton
Adrian
A
D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003402:Creatine Kinase / Q000378:metabolism; D006801:Humans; D008025:Ligases / Q000378:metabolism; D017563:Lung Diseases, Interstitial / Q000188:drug therapy*; D008297:Male; D000069283:Rituximab; D013577:Syndrome; D016896:Treatment Outcome
D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab; D003402:Creatine Kinase; D008025:Ligases